Immunological monitoring and clinical trials of biological response modifiers.
作者信息
Baseler M W, Kopp W C, Urba W J
机构信息
Program Resources Inc./Dyncorp, National Cancer Institute, Frederick Cancer Research and Development Center, MD.
出版信息
Cancer Chemother Biol Response Modif. 1993;14:249-83.
PMID:7508729
Abstract
摘要
相似文献
1
Immunological monitoring and clinical trials of biological response modifiers.
Cancer Chemother Biol Response Modif. 1993;14:249-83.
2
Immunological monitoring and clinical trials of biological response modifiers.
Cancer Chemother Biol Response Modif. 1991;12:231-50.
3
Immunological monitoring and clinical trials of biological response modifiers.
Cancer Chemother Biol Response Modif. 1988;10:473-91.
4
Immunological monitoring and clinical trials of biological response modifiers.
Cancer Chemother Biol Response Modif. 1994;15:226-86.
5
Immunological monitoring and clinical trials of biological response modifiers.
Cancer Chemother Biol Response Modif. 1990;11:281-302.
6
Immunological monitoring and clinical trials of biological response modifiers.
Cancer Chemother Biol Response Modif. 1992;13:205-29.
7
Cytokines and immunological monitoring.
Cancer Chemother Biol Response Modif. 1996;16:189-238.
8
Design of combination biotherapy studies: future goals and challenges.
Semin Oncol. 1990 Feb;17(1 Suppl 1):3-10; discussion 38-41.
9
Biological response modifiers.
Cancer Chemother Biol Response Modif. 1991;12:193-212.
10
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Strahlenther Onkol. 2004 Apr;180(4):187-93. doi: 10.1007/s00066-004-9119-x.
Zotero 插件